109 results
Page 2 of 6
8-K
EX-99.2
hdppr7z3 z12rdxgzh
22 Apr 24
Regulation FD Disclosure
7:15am
8-K
lhkrlk0g4gz1iz5 zvz
22 Apr 24
Regulation FD Disclosure
7:15am
8-K
EX-99.1
67rzs t6l7u
22 Apr 24
Regulation FD Disclosure
7:15am
8-K
EX-99.1
7qxp09hrgd
28 Mar 24
Centessa Pharmaceuticals Reports Business Highlights and Financial Results for the Fourth Quarter and Full-Year 2023
4:35pm
8-K
EX-99.1
2djbd1t6 rtevtjv
9 Feb 24
Regulation FD Disclosure
7:12am
8-K
EX-99.1
keegjy2uk8dwf81n9
9 Jan 24
Regulation FD Disclosure
7:56am
8-K
EX-99.1
msxj923c
11 Dec 23
Regulation FD Disclosure
7:05am
8-K
EX-99.2
reqw7vvs2vg2qwl4j1jh
11 Dec 23
Regulation FD Disclosure
7:05am
8-K
EX-99.1
9zmx0t3k wcqhpj6
13 Nov 23
Centessa Pharmaceuticals Reports Financial Results and Business Highlights for the Third Quarter of 2023
4:17pm
8-K
EX-99.2
b4b awd40wfcl7fahl
25 Oct 23
Regulation FD Disclosure
9:49am
8-K
EX-99.1
xn2g61m25twnb9t
25 Oct 23
Regulation FD Disclosure
9:49am
8-K
EX-99.2
vmhx qn59y
14 Aug 23
Centessa Pharmaceuticals Reports Financial Results and Business Highlights for the Second Quarter of 2023
7:06am
8-K
EX-99.1
7wve0fgyl ojbhsgg
14 Aug 23
Centessa Pharmaceuticals Reports Financial Results and Business Highlights for the Second Quarter of 2023
7:06am
8-K
EX-99.1
gqirt
10 Jul 23
Regulation FD Disclosure
5:00pm
8-K
EX-99.1
n59epia
9 Jun 23
Regulation FD Disclosure
7:10am
DEFA14A
8h1x5 6ih4
23 May 23
Additional proxy soliciting materials
4:08pm
8-K
EX-99.1
wign540z2g9u
22 May 23
Centessa Pharmaceuticals Receives Fast Track Designation from the U.S. FDA for SerpinPC for Hemophilia B
7:06am